Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 10,801-10,812 of 23,847
Behavioral study icon
Active Not RecruitingNCT07085143

Clinical Study of Compound Ciwujia Granules in the Treatment of Depression

This study is comparing Compound Ciwujia Granules with placebo for people with Depression - depression or Depression Disorders. Participants receive Compound Ciwujia Granules or placebo and complete study visits and assessments.

In Shanghai
DepressionBehavioralFrom 18 Years to 65 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Depression
Drug study icon
CompletedNCT00071747

Clinical Study Of Schizophrenia in Both Men and Women

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
GlaxoSmithKline
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05754554

Clinical Study of the Treatment of Chiari Malformation Combined With Type II Skull Base Depression

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

In Guangzhou
DepressionBehavioralFrom 18 Years to 60 Years
Countries
China
Sponsor
Southern Medical University, China
Condition
Depression
Behavioral study icon
CompletedNCT01674543

Clinical Symptoms of Schizophrenia and Physical Exercise

This summary needs review. Please check the official study record and contact the research team for details.

In São Paulo
SchizophreniaBehavioralFrom 18 Years to 50 Years
Countries
Brazil
Sponsor
Federal University of São Paulo
Condition
Schizophrenia
Drug study icon
CompletedNCT02600494

study Evaluating ITI-007 (Lumateperone) as a Monotherapy for Depression in bipolarity

This study exists to understand how the medication ITI-007 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication ITI-007 in practice and what may need to be adjusted.

Multiple locations, including Little Rock
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.